hydralazine has been researched along with Pregnancy in Diabetes in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreisberg, RA | 1 |
| Morgan, J | 1 |
| Carmichael, E | 1 |
| Pittman, J | 1 |
| Hussein, M | 1 |
| Mooij, JM | 1 |
| Roujouleh, H | 1 |
2 other studies available for hydralazine and Pregnancy in Diabetes
| Article | Year |
|---|---|
Medical grand rounds from the University of Alabama Medical Center.
Topics: Female; Humans; Hydralazine; Pre-Eclampsia; Pregnancy; Pregnancy in Diabetics | 1967 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; | 2001 |